Semi automatic quantification of REM sleep without atonia in natural sleep environment
Polysomnography, the gold standard diagnostic tool in sleep medicine, is performed in an artificial environment. This might alter sleep and may not accurately reflect typical sleep patterns. While macro-structures are sensitive to environmental effects, micro-structures remain more stable. In this study we applied semi-automated algorithms to capture REM sleep without atonia (RSWA) and sleep spindles, comparing lab and home measurements. We analyzed 107 full-night recordings from 55 subjects: 24 healthy adults, 28 Parkinson's disease patients (15 RBD), and three with isolated Rem sleep behavior disorder (RBD). Sessions were manually scored. An automatic algorithm for quantifying RSWA was developed and tested against manual scoring. RSWAi showed a 60% correlation between home and lab. RBD detection achieved 83% sensitivity, 79% specificity, and 81% balanced accuracy. The algorithm accurately quantified RSWA, enabling the detection of RBD patients. These findings could facilitate more accessible sleep testing, and provide a possible alternative for screening RBD.
Authors
- Andrew Dagay
- Riva Tauman (ORCID: https://orcid.org/0000-0002-6574-3601)
- Daniel Possti
- Yael Hanein (ORCID: https://orcid.org/0000-0002-4213-9575)
- Iain Duncan (ORCID: https://orcid.org/0000-0002-8473-9755)
- Matteo Cesari (ORCID: https://orcid.org/0000-0001-6554-1033)
- Aaron Gerston (ORCID: https://orcid.org/0000-0001-8773-4100)
- Shani Oz
- Danielle Wasserman (ORCID: https://orcid.org/0000-0002-4150-7831)
- Anat Mirelman
Institutions
- Guy's Hospital (GB)
- Innsbruck Medical University (AT)
- Tel Aviv University (IL)
- Universität Innsbruck (AT)
- Tel Aviv Sourasky Medical Center (IL)
- Shaare Zedek Medical Center (IL)
- National Tax College (JP)
Publication Details
- Journal
- npj Digital Medicine
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1038/s41746-024-01354-8
- Citations
- 10
- Primary Topic
- Sleep and Wakefulness Research
- Type
- article
- Field-Weighted Citation Impact
- 3.43
Funders
- U.S. Department of Defense
- Teva Pharmaceutical Industries